Cardiac tumors, though rare, pose significant challenges in cancer research. These tumors can be either benign or malignant and originate from various cell types within the heart. Understanding their biology, progression, and treatment options is crucial due to their potential to cause life-threatening complications such as heart failure, arrhythmias, and embolisms. Advanced imaging techniques like MRI and CT scans aid in diagnosis, while surgical resection remains the primary treatment for localized tumors. However, recurrence rates are high, highlighting the need for targeted therapies and innovative treatment approaches. Ongoing research focuses on unraveling the genetic and molecular mechanisms underlying cardiac tumors, paving the way for personalized treatments and improved patient outcomes in this relatively understudied field of oncology.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States